No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas

byTeddy Guo

September 30, 2021

in StudyGraphics

Reading Time: 1 min read

Wellness Check: Exercise

RelatedReports

Nivolumab may be effective in platinum-resistant ovarian cancer

Surgery

Perioperative toripalimab improves event-free survival in non-small cell lung cancer

August 9, 2026

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy

August 6, 2026

No significant increased risk of bladder cancer with pioglitazone use

Oncology

All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia

July 23, 2026

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Chronic Disease

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

July 15, 2026

$#VisualAbstract Adding uproleselan to chemotherapy in patients with relapsed or refractory acute myeloid leukemia was well-tolerated with high remission rates$

#VisualAbstract Adding uproleselan to chemotherapy in patients with relapsed or refractory acute myeloid leukemia was well-tolerated with high remission rates

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Contact aspiration with stent retrieval no more effective than stent retrieval alone for thrombectomy revascularization in stroke patients

Earlier puberty associated with increased risk of depression in girls

Placebo effect size in treatment-resistant depression in adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports